Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA-Reference-Cited by-同舟云学术

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA

Published:2018-01-12 Issue:8 Volume:24 Page:1872-1880
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Goldberg Sarah B.,Narayan Azeet,Kole Adam J.,Decker Roy H.,Teysir Jimmitti,Carriero Nicholas J.,Lee Angela,Nemati Roxanne,Nath Sameer K.,Mane Shrikant M.,Deng Yanhong,Sukumar Nitin,Zelterman Daniel,Boffa Daniel J.,Politi Katerina,Gettinger Scott N.,Wilson Lynn D.,Herbst Roy S.,Patel Abhijit A.

Funder

National Cancer Institute

Yale

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 324 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group;Cancers;2024-09-09

2. Liquid biopsy: paving a new avenue for cancer research;Cell Adhesion & Migration;2024-09

3. Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy;Nature Communications;2024-08-10

4. Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC;Scientific Reports;2024-08-09

5. A novel machine learning model for efficacy prediction of immunotherapy-chemotherapy in NSCLC based on CT radiomics;Computers in Biology and Medicine;2024-08